Medical Net, Inc. completed the acquisition of additional 12.1% of the shares of MiRTeL Co., Ltd from HC No. 8 Fund and High-Value C 1st Fund managed by Hiroshima Venture Capital Co., Ltd., Furusato Renkei Ouen Fund managed by Hiroshima Innovation Network Inc., Will Group Fund Investment Limited Partnership managed by Future Venture Capital Co., Ltd. and 4 others.
January 04, 2024
Share
Medical Net, Inc. (TSE:3645) entered into a contract to acquire additional 12.1% of the shares of MiRTeL Co., Ltd from HC No. 8 Fund and High-Value C 1st Fund managed by Hiroshima Venture Capital Co., Ltd., Furusato Renkei Ouen Fund managed by Hiroshima Innovation Network Inc., Will Group Fund Investment Limited Partnership managed by Future Venture Capital Co., Ltd. and 4 others December 21, 2023. As part of acquisition, 65,667 shares will be acquired. Earlier on November 27, 2023, Medical Net agreed to acquire additional 56.4% stake in MiRTeL Co., Ltd from Toshiya Kato, Hidetoshi Tahara, Naoki Tomokami, Eiji Tahara and Yoshino Tahara on November 27, 2023. Following both transactions, Medical Net holds 71.1% stake in MiRTeL. Both the transaction is expected to complete on January 5, 2024.
Medical Net, Inc. (TSE:3645) completed the acquisition of additional 12.1% of the shares of MiRTeL Co., Ltd from HC No. 8 Fund and High-Value C 1st Fund managed by Hiroshima Venture Capital Co., Ltd., Furusato Renkei Ouen Fund managed by Hiroshima Innovation Network Inc., Will Group Fund Investment Limited Partnership managed by Future Venture Capital Co., Ltd. and 4 others on January 5, 2024.
Future Venture Capital Co., Ltd. is a Japan-based company mainly engaged in the venture capital business. The Company operates businesses in Japan and Colorado, United Stated. Venture Capital business is engaged in the investment and investment advices services to venture companies, the composition, management and operation of investment partnerships, and the selection and development of investment destinations. The Company also addresses other revenue opportunities associated with those activities.
Medical Net, Inc. completed the acquisition of additional 12.1% of the shares of MiRTeL Co., Ltd from HC No. 8 Fund and High-Value C 1st Fund managed by Hiroshima Venture Capital Co., Ltd., Furusato Renkei Ouen Fund managed by Hiroshima Innovation Network Inc., Will Group Fund Investment Limited Partnership managed by Future Venture Capital Co., Ltd. and 4 others.
FUTURE VENTURE CAPITAL CO., LTD. 
